Ekso Bionics Holdings, Inc. - Common Stock (EKSO)
Frequently Asked Questions About Ekso Bionics Holdings, Inc. - Common Stock (EKSO)
Can Ekso Bionics products be used at home?
Currently, Ekso Bionics products like the EksoGT are primarily designed for use in clinical rehabilitation settings, as they require trained personnel for optimal operation and supervision. However, the company is exploring options to adapt its technology for greater accessibility, including potential applications for home use.
Does Ekso Bionics have any partnerships?
Yes, Ekso Bionics has established various partnerships with healthcare institutions, rehabilitation centers, and technology companies to enhance research, development, and deployment of its exoskeleton products. These partnerships help facilitate clinical trials and improve integration of the technology within therapeutic practices.
How can investors learn more about Ekso Bionics?
Investors can learn more about Ekso Bionics by visiting the company's official website, where they can access financial reports, press releases, and corporate announcements. Additionally, the company provides investor relations resources and participates in investor conferences to share its vision and progress.
How does Ekso Bionics engage with its customers?
Ekso Bionics engages with its customers through various channels, including direct sales, support for rehabilitation providers, and feedback mechanisms for users. The company often participates in industry conferences and forums to strengthen relationships and gather insights that help tailor their products to meet customer needs.
How does the EksoGT work?
The EksoGT works by using sensors and motors to assist users in standing and walking. The device detects the user’s intentions and movements through pressure sensors and accelerometers, allowing it to provide support during the natural gait cycle, thereby aiding in rehabilitation and promoting motor function recovery.
Is Ekso Bionics publicly traded?
Yes, Ekso Bionics is publicly traded on the NASDAQ under the ticker symbol EKSO. The company became a publicly traded entity to raise funds for its research and development efforts and to expand its market reach in the bionics industry.
What are Ekso Bionics' main products?
Ekso Bionics' main products include the EksoGT, a robotic exoskeleton designed for rehabilitation of patients with lower limb disabilities, and the EksoWorks, intended for use in industrial settings. These products assist users in improving their mobility, strength, and independence, whether for therapeutic or professional purposes.
What are the future prospects for Ekso Bionics?
The future prospects for Ekso Bionics look promising, with ongoing advancements in robotic technology and increasing demand for innovative rehabilitation solutions. The company is focused on expanding its market presence globally, enhancing product offerings, and addressing diverse needs across different sectors.
What are the potential benefits of using Ekso Bionics exoskeletons?
The potential benefits of using Ekso Bionics exoskeletons include improved mobility and strength, reduced dependency on caregivers, enhanced rehabilitation outcomes, and increased quality of life for users. The technology aims to aid in physical recovery and promote independence in daily activities.
What does Ekso Bionics Holdings, Inc. do?
Ekso Bionics Holdings, Inc. develops and commercializes exoskeletons designed to enhance human capabilities. The company's products are primarily focused on rehabilitation and mobility, providing innovative solutions for individuals with various physical challenges, including those recovering from strokes or spinal cord injuries.
What industries does Ekso Bionics serve?
Ekso Bionics primarily serves the healthcare industry, particularly in rehabilitation and physical therapy. The company’s devices are used in hospitals and rehabilitation centers, facilitating physical therapy for patients with injuries or disabilities, as well as in the military and industrial sectors to aid workers in physically demanding tasks.
What is the company's mission?
Ekso Bionics' mission is to empower individuals with physical challenges by providing innovative bionic products that enhance mobility and independence. The company aims to revolutionize rehabilitation and workplaces through technology that bridges the gap between human limitations and enhanced abilities.
What is the regulatory status of Ekso Bionics products?
Ekso Bionics products are subject to rigorous regulatory assessment. The EksoGT, for instance, is FDA-cleared for use in rehabilitation settings, ensuring compliance with safety and effectiveness standards in medical devices. Ongoing regulatory efforts are crucial for the company's operations and market acceptance.
What is the target audience for Ekso Bionics products?
The primary target audience for Ekso Bionics products includes patients recovering from neurological conditions such as strokes or spinal cord injuries, as well as healthcare professionals utilizing the devices in physical rehabilitation. Additionally, the company also engages industries needing ergonomic solutions, such as manufacturing and construction.
What recent developments has Ekso Bionics announced?
Recent developments from Ekso Bionics have included advancements in their technology, such as improved software for their exoskeletons, partnerships with rehabilitation institutions, and initiatives to expand their product offerings in varied markets, reflecting the company's commitment to innovation and accessibility.
What role does research and development play in Ekso Bionics?
Research and development (R&D) play a pivotal role in Ekso Bionics' strategy, driving innovation and the advancement of technologies that enhance the functionality and usability of their products. R&D efforts are focused on improving user experience, integrating new technology, and expanding clinical evidence supporting their exoskeleton applications.
When was Ekso Bionics founded?
Ekso Bionics was founded in 2005. Since its inception, the company has focused on advancing technology in the field of robotics and biomechanics, aiming to improve the lives of people with mobility impairments through its range of exoskeleton systems.
Where is Ekso Bionics headquartered?
Ekso Bionics is headquartered in Richmond, California. This location allows the company to be strategically placed within a hub of innovation and technology, facilitating collaboration and access to resources needed for the development of advanced bionic solutions.
Who are the key members of the Ekso Bionics leadership team?
The key members of the Ekso Bionics leadership team typically include experienced professionals from the fields of robotics, healthcare, and business management. This often includes the CEO, CFO, and other executives who play a crucial role in driving the company's strategic initiatives and growth.
What is the current price of Ekso Bionics Holdings, Inc. - Common Stock?
The current price of Ekso Bionics Holdings, Inc. - Common Stock is 0.4150
When was Ekso Bionics Holdings, Inc. - Common Stock last traded?
The last trade of Ekso Bionics Holdings, Inc. - Common Stock was at 4:00 pm EDT on April 2nd, 2025
What is the market capitalization of Ekso Bionics Holdings, Inc. - Common Stock?
The market capitalization of Ekso Bionics Holdings, Inc. - Common Stock is 5.91M
How many shares of Ekso Bionics Holdings, Inc. - Common Stock are outstanding?
Ekso Bionics Holdings, Inc. - Common Stock has 14.23M shares outstanding.